Fact CheckerSign in

NCT06153017Active, not recruiting

iTMS - Implementing Transcranial Magnetic Stimulation (TMS) to Assess Cortico-spinal Tract Integrity

Source: ClinicalTrials.gov · Last updated 21 May 2025

Brief summary (registry, in English)

Reliable prediction of upper limb (UL) function can guide clinicians in choosing relevant treatment, helps to set realistic goals for rehabilitation and will contribute to personalized and effective rehabilitation. TMS has been identified as a strong predictor of future UL function after stroke. With this project, the investigators want to implement the standard use of TMS examination for a defined patient group in the clinical setting and systematically evaluate the implementation process. The impact and perceived value of TMS in the clinical setting will be evaluated and the predictive value of TMS for the specific patient population will be assessed.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
14 Jun 2023
Start date
1 May 2023
Primary completion date
31 Dec 2025
Lead sponsor
University of Aarhus
Diseases
Stroke
NCT number
NCT06153017

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 May 2023 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Metal implants in the head

Other illness

  • Epilepsy
  • Other implanted electronics (cardiac pacemaker, defibrillator, cochlear implant, medication pump)

Other

  • Skull fracture or serious head injury
  • Pregnancy

Who the study is looking for

  • admitted to rehabilitation within 21 days after stroke
  • severe UL impairment, either paralysis (no active movement), or severe paresis, defined as Fugl-Meyer Assessment \<17 or Shoulder Abduction Finger Extension (SAFE) score \< 5
  • At least 18 years old
  • able to provide informed consent and comply with examination procedures

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hammel neurorehabilitation centre and university research clinic
Coordinator of this site? Confirm its status
HammelDenmarkUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.